TUALATIN, Ore.--(BUSINESS WIRE)--QuantRx® Biomedical Corporation ("QuantRx" or the "Company") (OTCBB: QTXB) and Global Cancer Diagnostics Inc. (“Global”), a privately held laboratory, jointly announce that they have signed a letter of intent to combine. Global, a CLIA-certified diagnostics laboratory based in Tempe, Arizona, has developed a low cost, highly accurate over-the-counter lung cancer screening test marketed under the name “The Lung Cancer Test™”. Global’s proprietary technology combines low reagent and labor costs to provide an affordable self-pay solution. “The Lung Cancer Test™” serves as a screening tool providing risk assessment, and is being sold as a laboratory developed test. Global’s management brings deep industry knowledge and expertise in the areas of medical laboratory operations and CLIA laboratory licensing, as well as the marketing of blood tests.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
